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Protein traffic from the cell surface or the trans-Golgi network reaches the lysosome via a series of
endosomal compartments. One of the last steps in the endocytic pathway is the fusion of late
endosomes with lysosomes. This process has been reconstituted in vitro and has been shown to
require NSF, a and g SNAP, and a Rab GTPase based on inhibition by Rab GDI. In Saccharomyces
cerevisiae, fusion events to the lysosome-like vacuole are mediated by the syntaxin protein Vam3p,
which is localized to the vacuolar membrane. In an effort to identify the molecular machinery that
controls fusion events to the lysosome, we searched for mammalian homologues of Vam3p. One
such candidate is syntaxin 7. Here we show that syntaxin 7 is concentrated in late endosomes and
lysosomes. Coimmunoprecipitation experiments show that syntaxin 7 is associated with the
endosomal v-SNARE Vamp 8, which partially colocalizes with syntaxin 7. Importantly, we show
that syntaxin 7 is specifically required for the fusion of late endosomes with lysosomes in vitro,
resulting in a hybrid organelle. Together, these data identify a SNARE complex that functions in
the late endocytic system of animal cells.
INTRODUCTION
Endocytosed proteins that do not recycle to the plasma
membrane or the trans-Golgi network are ultimately deliv-
ered to the lysosome. As one of the primary sites for protein
degradation, lysosomes are also the recipients of phagocy-
tosed material and autophagized proteins. There are ample
data to support the view that all of these pathways converge
in a late endocytic compartment before fusion with the
lysosome (Futter et al., 1996; Mellman, 1996; Storrie and
Desjardins, 1996; Bright et al., 1997). However, little is
known about the molecular mechanisms that mediate this
fusion process.
The process of fusion between late endosomes and lyso-
somes has been examined both in vivo and in vitro. This
process is characterized by the formation of a hybrid or-
ganelle with intermediate properties of both compartments,
implying that continued efflux of material from this hybrid
is required for the ultimate reformation of dense lysosomes
(Bright et al., 1997; Mullock et al., 1998; Luzio et al., 2000;
Pryor et al., 2000). An alternative hypothesis is that late
endosomes transfer their cargo to lysosomes by an abbrevi-
ated “kiss-and-run” scenario (Storrie and Desjardins, 1996).
Both of these models, unlike the notion that lysosomes “ma-
ture” from endocytic compartments, rely on a highly specific
fusion event with preexisting lysosomes (Mellman, 1996).
Previous studies have identified a few molecular players
involved in late endosome and lysosome fusion, such as
NSF and a Rab GDI-sensitive GTPase. However, a better
understanding of this overall process will require more de-
tailed characterization of the proteins that mediate this spe-
cific fusion event (Mullock et al., 1998).
During the last few years, the SNARE hypothesis has
provided a compelling mechanistic model for a number of¶ Corresponding author. E-mail address: robert-piper@uiowa.edu.
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fusion events throughout the secretory and endocytic path-
ways (Rothman and Warren, 1994; Rothman and Wieland,
1996), with particular combinations of SNAREs mediating
distinct fusion events in vivo (Bennett, 1995). The SNARE
proteins form a very stable parallel array of coiled-coil do-
mains forming a four-helix bundle; it is thought that the
formation of this complex may provide some of the energy
that drives vesicle fusion (Hanson et al., 1997; Poirier et al.,
1998; Sutton et al., 1998; Weber et al., 1998). Because both
v-SNARE and t-SNARE proteins have been found in trans-
port vesicles and target organelles, it can be more useful to
categorize v- and t-SNAREs as R- and Q-SNAREs, respec-
tively, according to their structural composition (Fasshauer
et al., 1998; Sutton et al., 1998). Although the stoichiometry of
the core complex may differ depending on the particular set
of SNARE proteins (Carr et al., 1999; Ungermann et al., 1999),
in general, v-SNAREs contribute a critical arginine residue
in the interior of the bundle that is aligned with glutamine
residues contributed by each of the three helices from the
t-SNAREs to form a core complex (Sutton et al., 1998). What
remains unclear about SNARE-mediated transport steps,
however, is exactly which steps are mediated by some of the
more recently described SNARE proteins as well as what
regulates the specificity of these steps, especially throughout
the endocytic pathway, where the role of vesicular transport
is less certain.
In Saccharomyces cerevisiae, the process of vacuolar biogen-
esis parallels that of lysosomal biogenesis in mammalian
cells (Bryant and Stevens, 1998). Many of the t-SNARE pro-
teins that act at discrete trafficking steps along the mamma-
lian secretory pathway display the greatest level of identity
with the yeast t-SNARE that functions in an analogous step
(i.e., Sed5p is most similar to syntaxin 5, and Sso1p/Sso2p
are most similar to syntaxins 1–4) (Aalto et al., 1993; Banfield
et al., 1994; Rowe et al., 1998). It is likely that similar parallels
will be found in the endocytic pathway. The yeast syntaxin
Vam3p has been localized to the yeast vacuole and is re-
quired for the delivery of vacuolar proteins that follow a
variety of membrane trafficking pathways (Darsow et al.,
1997; Piper et al., 1997; Wada et al., 1997). Vam3p is required
for homotypic vacuole fusion (Nichols et al., 1997; Unger-
mann et al., 1998), fusion of endosomal compartments and
prevacuolar autophagic organelles with the vacuole (Dar-
sow et al., 1997), and fusion of a new type of transport
intermediate that carries the membrane protein alkaline
phosphatase to the vacuole (Piper et al., 1997; Rehling et al.,
1999). Recently, a Vam3-related protein was identified in
Arabidopsis thaliana that is likely to have similar functions to
the yeast Vam3p, given its localization to the plant vacuole.
Because of the prominent role of Vam3p in a variety of
fusion events with the vacuole, we sought to identify a
t-SNARE from mammalian cells that may functionally cor-
respond to Vam3p. With this aim, we identified mammalian
syntaxin 7 with the highest level of homology to S. cerevisiae
and A. thaliana Vam3 proteins. Syntaxin 7 (Syn7) was orig-
inally proposed to participate in traffic from the trans-Golgi
network to the endocytic system based on its sequence sim-
ilarity to Pep12p (Wang et al., 1997); and partial colocaliza-
tion of Syn7 with markers of early endosomes suggested a
role in fusion events within the early endocytic system
(Wong et al., 1998b). Our studies, however, show that Syn7
is concentrated in late endosomes and lysosomes and can be
isolated in a complex with Vamp 8. Importantly, we find
that Syn7 is required for the fusion of late endosomes with
lysosomes with the use of an in vitro content-mixing assay.
Together, these data suggest that Syn7 plays a pivotal role in
the final steps of lysosomal biogenesis.
MATERIALS AND METHODS
Materials
Enzymes used in DNA manipulations were from New England
Biolabs (Beverly, MA), Boehringer Mannheim Biochemicals (India-
napolis, IN), Bethesda Research Laboratories (Gaithersburg, MD),
or United States Biochemical (Cleveland, OH). Radioactive materi-
als were purchased from New England Nuclear (Boston, MA), and
nitrocellulose membranes were from Micron Separations Inc. (West-
borough, MA). All tissue culture reagents were from Life Technol-
ogies (Gaithersburg, MD). Bicinchoninic acid protein reagent was
from Pierce (Rockford, IL). Glutathione–agarose beads were from
Pharmacia (Uppsala, Sweden). Fixed Staphylococcus aureus cells (IgG
Sorb) were purchased from the Enzyme Center (Walden, MA). All
other chemicals were of high-purity commercial grade. Oregon
Green– and Texas Red–conjugated goat anti-rabbit and anti-mouse
secondary antibodies, biotinylated anti-rabbit antibodies, and Alexa
488–conjugated streptavidin were purchased from Molecular
Probes (Eugene, OR). FITC- and Texas Red–conjugated donkey
anti-rabbit and anti-goat secondary antibodies were purchased from
Jackson Laboratories (West Grove, PA). HRP-conjugated goat anti-
rabbit immunoglobulin G (IgG) and ECL detection kits were from
Amersham (Arlington Heights, IL).
DNA and Plasmid Constructions
DNA manipulations and DNA-mediated transformation were per-
formed by routine procedures (Sambrook et al., 1989). A BLAST
search through the Merck/Washington University expressed se-
quence tag database revealed several putative ORFs that encoded
proteins related to Vam3p (Altschul et al., 1990). We amplified one
of these (H33185) with the oligonucleotides CCATTTCCAGAG-
TATCGGGTGGC and TCTATGCTCTCAATAACATCTCC. This
PCR fragment was used to probe a mouse 3T3-L1 cDNA library as
described previously (Tellam et al., 1997). A full-length clone was
isolated and sequenced to reveal an ORF of 266 amino acids (Gen-
Bank accession number AFO56323). Sequence comparison analysis
was performed with the DNASTAR (Madison, WI) MegAlign soft-
ware with the use of the Clustal algorithm.
The plasmid pGSTSyn7a encoding a GST–Syn7 fusion protein
was made by PCR amplifying codons 2–242 of the Syn7 ORF and
subcloning the fragment into the BamHI–EcoRI sites of pGEX-3X
with the use of the oligonucleotides CACAGGATCCAGTCTTA-
CACTCCGGGGATTGG and CTCCAATTCTAAGTTTTCCTG-
GATTTGCGCTGA (Smith and Johnson, 1988). The plasmid
pCWS002 encoding a GST–Vamp 8 protein was made by reverse
transcription–PCR amplifying codons 1–76 of the mouse Vamp 8
ORF and subcloning the fragment into the BamHI–Xho sites of
pGEX-4T3 with the use of the oligonucleotides CCGGGATCCAT-
GGAGGAGGCCAGTGGG and CCGCTCGAGTTACATCTTCA-
CATTCTTCCA. Northern analysis on whole RNA was conducted
as described previously with the use of the entire cDNA as probe or
with a glyceraldehyde-3-phosphate dehydrogenase cDNA probe as
an internal control (Tellam et al., 1997).
An expression plasmid (pRCP316) that expressed a hemaggluti-
nin (HA) epitope–tagged Syn7 was made by amplifying the com-
plete ORF of mouse Syn7 with the oligonucleotides ATGTATCCT-
TACGACGTACCAGATTACGCATACCCCATATGATGTTCCTG-
ACTATGCGTCTTACACTCCGGGGATTGGT and TCAGCCTT-
TCAGTCCCCATACGA and subcloning the resulting fragment into
pCDNA-V5–6XHIS (Invitrogen, Carlsbad, CA). Both strands of the
resulting construct were sequenced for orientation and fidelity of
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amplification. The resulting plasmid expressed the Syn7 ORF pre-
ceded by two tandem repeats of the HA epitope (YPYDVPDYAG).
A GST–syntaxin 13 (Syn13) fusion construct encoding amino ac-
ids 1–243 of rat Syn13 was kindly provided by Dr. Rohan Teasdale
(Monash Medical Center, Melbourne, Australia).
Antibodies
Polyclonal anti-GST antibodies and polyclonal and monoclonal anti-
Syn7 antibodies were raised against the GST–Syn7 fusion protein
encoded by pGSTSyn7a. Anti-Vamp 8 antibodies were raised
against the GST–Vamp 8 fusion protein encoded by pCWS002.
The bacterial fusion proteins were purified over glutathione–
agarose and eluted with 25 mM glutathione as reported previously
(Smith and Johnson, 1988). Two rabbit polyclonal antibodies (#1 and
#2) and one goat polyclonal antibody to Syn7 were raised and were
purified similarly. Rabbit immunizations were performed as de-
scribed previously (Roberts et al., 1989). Serum from immunized
animals was subjected to a series of affinity purification steps to
yield specific antibodies to GST and Syn7. Serum was first passed
over an Affigel column (Affigel 10 and Affigel 15, Bio-Rad, Hercules,
CA) to which GST was attached. Anti-GST antibodies were eluted in
0.2 M glycine, pH 2.5, and dialyzed in three changes of PBS. The
remaining serum that was depleted of anti-GST antibodies was then
applied to another Affigel column to which the GST–Syn7 fusion
protein was attached. Antibodies were eluted in 0.2 M glycine, pH
2.5, and dialyzed in three changes of PBS. Monovalent Fab frag-
ments of rabbit anti-Syn7#2 IgG were prepared according to Coulter
and Harris (1983) and then affinity purified like the intact antibod-
ies. Antibodies specific to Vamp 8 were purified similarly. One
antiserum raised against the C-terminal tail of the cation-indepen-
dent mannose-6-phosphate receptor (CI-MPR) was a kind gift from
Dr. Gwyn Gould (University of Glasgow, Glasgow, Scotland), and a
second was as described previously (Reaves et al., 1996). Affinity-
purified anti-Rab7 rabbit polyclonal antibodies were a kind gift of
Marino Zerial (EMBL, Heidelberg, Germany). mAbs to the trans-
ferrin receptor were purchased from Zymed Laboratories (San Fran-
cisco, CA) and Chemicon (mAb 1451; Temecula, CA). Monoclonal
anti-syntaxin 6 and anti-early endosome–associated protein 1
(EEA1) antibodies were purchased from Transduction Laboratories
(Lexington, KY). mAbs to the HA epitope were purchased from
BAbCO (Berkeley, CA). Polyclonal anti-syntaxin 6 antibodies were
affinity purified over a GST–syntaxin 6 affinity column as described
previously (Tellam et al., 1997). mAbs to rat lgp120 were as de-
scribed previously (Grimaldi et al., 1987; Reaves et al., 1996). Rabbit
polyclonal antibodies to rat lgp120 were a gift from Keitaro Kato,
Yoshitake Tanaka, and Masaru Himeno (Kyushu University,
Fukuoka, Japan) (Furuno et al., 1989). Anti-Syn13 antibodies were
raised against the GST–Syn13 fusion protein or were a gift of
Marino Zerial. Rabbit polyclonal antibodies to EEA1 were used as
described previously (Mu et al. 1995). Anti-Syn13 antibodies were
raised against the GST–Syn13 fusion protein (antiserum 4972) or
were a kind gift from Marino Zerial.
For the production of the monoclonal anti-Syn7 antibody
Syn7.1C3, hybridoma cell lines were produced and characterized as
described previously (Brooks et al., 1997). Positive clones were
screened for reactivity to the GST–Syn7 fusion protein by ELISA
and assessed for specificity by screening for reactivity to GST–Syn13
and GST fusion proteins. Hybridoma culture supernatant was pu-
rified on a 0.1-ml protein G cartridge (Pharmacia) and eluted with
0.1 M NaH2PO4, pH 2.5, into 100 ml of 1 M Na2HPO4, pH 9.0, and
then dialyzed against three changes of PBS.
Cell Culture
Madin-Darby canine kidney (MDCK) cells and normal rat kidney
(NRK) cells were grown at 37°C in an atmosphere of 5% CO2 in
DMEM supplemented with 10% FCS, 2 mM l-glutamine, 100 U/l
penicillin, 100 mg/l streptomycin, and 0.1 mM MEM nonessential
amino acid solution. Cells were grown to near confluence in either
150-mm culture dishes for membrane preparation and cryosection
immunoelectron microscopy or on coverslips for immunofluores-
cence microscopy.
WIF-B cells were grown as described (Ihrke et al., 1993) with some
modifications. Briefly, cells were grown in Cassio modified Ham’s
F12 medium (GIBCO/BRL, Grand Island, NY) supplemented with
10 mM hypoxanthine, 0.04 mM aminopterin, 1.6 mM thymidine, and
3.5% FCS (Hyclone, Logan, UT). For experiments, cells were plated
on glass coverslips at 0.8–1.2 3 106 cells/cm2 and cultured until
they had reached maximal polarization (10–14 d after plating).
For transfection studies, cells were grown until 50% confluent and
washed three times in sterile PBS. DNA was transfected with Lipo-
fectamine according to the manufacturer’s directions (Life Technol-
ogies) for 10 h in serum-free DMEM. Transfection medium was
replaced with DMEM containing 10% FCS, and cells were allowed
to incubate for an additional 48 h. Cells were then cultured in 1
mg/ml geneticin for 10 d, after which colonies were isolated and
screened for expression of HA epitope–tagged Syn7.
Cell Fractionation
Whole cell extracts and whole membrane fractions were prepared
from rat tissues that were dissected and stored at 285°C. Tissues
were minced in PBS containing PMSF, leupeptin, and a-tosyl-l-
lysine chloromethyl ketone hydrochloride at 4°C and then homog-
enized by 25–30 strokes with a Teflon/glass Dounce. After a 1500 3
g spin for 2 min, the supernatant fractions were solubilized in
Laemmli sample buffer to make whole cell extracts.
Isolation of rat liver fractions enriched in late endosomes, hybrid
organelles, or lysosomes was performed as described previously
(Mullock et al., 1998). Briefly, endosome/lysosome hybrid or-
ganelles formed after the content-mixing assay incubation were
isolated at the 20% Nycodenz/20% Ficoll interface of a step gradi-
ent. Electron-dense lysosomes were collected from a preparative
45%/20% Nycodenz step gradient. Late endosomes were isolated
from a preparative 1–22% Ficoll gradient.
Immunofluorescence
Immunofluorescence on MDCK cells was performed with cells that
were grown on glass coverslips until 50% confluent. Cells were
fixed for 20 min in 2% paraformaldehyde in PBS at 25°C and
permeabilized for 15 min in 0.2% Triton X-100 containing 50 mM
glycine. Cells were washed in PBS containing 2% donkey serum and
labeled with primary antibodies for 1 h at 25°C. After this incuba-
tion, the cells were washed three times in PBS for 5 min and then
incubated for 30 min with conjugated secondary antibodies diluted
at 1:250 in PBS containing 1% donkey serum. For double-labeling
experiments with the use of rabbit anti-Syn7 antibodies in combi-
nation with a mouse mAb, Oregon Green–conjugated goat anti-
rabbit and Texas Red–conjugated goat anti-mouse secondary anti-
bodies were used. For double-labeling experiments with the use of
goat anti-Syn7 antibodies in combination with a rabbit polyclonal
antibody, FITC-conjugated donkey anti-goat and Texas Red–conju-
gated donkey anti-rabbit secondary antibodies were used. After this
incubation, the cells were washed three times in PBS for 5 min and
the coverslips were mounted onto slides in mounting medium (50%
glycerol/1% N-propyl gallate in PBS).
As a test for the specificity of immunofluorescence labeling, par-
allel antibody solutions, containing a 1:300 dilution of rabbit or goat
anti-Syn7 primary antibodies in PBS with 5% donkey serum, were
incubated with no additions or 300 mg/ml purified GST–Syn13
fusion protein or 300 mg/ml GST–Syn7 fusion protein at room
temperature for 2 h. Antibody solutions were then used to label
parallel coverslips of MDCK cells. Photography was performed
with the use of a set exposure and the same normalization settings.
For immunofluorescence localization in transfected NRK cells,
cells were grown on coverslips until 50% confluent. Cells were
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washed three times in PBS at 25°C and then fixed in 100% methanol
for 20 min at 220°C. Cells were then labeled with primary and
secondary antibodies as described above.
Polarized WIF-B cells grown on coverslips were fixed for 2 min in
3% paraformaldehyde/0.05% glutaraldehyde in PBS in the presence
of 0.2% sodium metabisulfite at 37°C, rinsed with PBS, and incu-
bated with 0.5% sodium borohydride for 10 min at room tempera-
ture. Cells were incubated in 1% BSA/0.1% saponin in PBS for 30
min and then incubated for 1 h with primary antibodies diluted in
0.5% BSA/0.25% saponin in PBS. The rabbit anti-Syn13 antiserum
(number 4972, 1:200) contained 300 mg/ml GST (preincubated for 30
min before adding to cells). Purified mouse IgG to Syn7 and affinity-
purified anti-Vamp 8 were used at 10 mg/ml; mouse ascites fluid to
lgp120 and mAb 1451 to the transferrin receptor were diluted 1:400
and 1:50, respectively; rabbit antiserum to lgp120 was diluted 1:300.
After washes with PBS, the cells were incubated for 30 min with
FITC- or Cy3-conjugated secondary antibodies (at 10 and 4 mg/ml,
respectively). Cells were mounted in Prolong Antifade (Molecular
Probes).
Images were captured with a Hamamatsu (Shizuoka, Japan)
ORCA charge-coupled device camera mounted on an Olympus
(Tokyo, Japan) BX-60 microscope equipped with a 603 oil objective
(numerical aperture 1.4). In instances stated, a 4-mm z series was
collected with a z-step of 0.1 mm (40 sections total) with a Ludl
(Hawthorne, NY) z-stepper for each fluorophore. Image stacks were
then subjected to a constrained iterative deconvolution algorithm
(Agard et al., 1989) with the use of Microtome software (Vaytek,
Fairfield, IA) and empirically determined point spread functions
with the use of blue, green, and red fluorescent 0.2-mm micro-
spheres (Molecular Probes). Paired sets of 10 images from each stack
(1 mm thick) were combined by making maximum point projections
and then overlaying the images with the use of Adobe Photoshop
(Adobe Systems, Mountain View, CA). Alternatively, confocal im-
ages were taken with a Leica (Bucks Milton Keynes, UK) TCS SP
system, a Zeiss (Thornwood, NY) LSM 510 laser scanning micro-
scope, or a Bio-Rad laser scanning system, all equipped with 633
Plan-Apo objectives (numerical aperture 1.4). Images were collected
at a resolution of 1024 3 1024 pixels. Adobe Photoshop software
was used for image processing.
Immunogold Electron Microscopy on Isolated
MDCK Membranes and Rat Liver Membranes
Preparation of membranes before fixation was performed at 0–4°C
with the use of a procedure described previously (Martin et al.,
1996). MDCK cells were washed three times in HES buffer (20 mM
HEPES, 250 mM sucrose, 1 mM EDTA, pH 7.4), scraped in HES
buffer (5 ml) containing protease inhibitors (10 mg/ml leupeptin, 10
mg/ml aprotinin, 250 mM PMSF), and homogenized by 10 passes
through a 22-gauge needle. A postnuclear supernatant was obtained
by centrifugation at 9600 3 g (SS-34 rotor, Sorvall Instruments,
Wilmington, DE); it was then layered onto a 1.5 M sucrose cushion
(containing 20 mM HEPES, pH 7.4, and 1 mM EDTA) and centri-
fuged at 154,000 3 g (SW-41 rotor, Beckman Instruments, Fullerton,
CA) for 1 h. The intracellular membrane fraction above the 1.5 M
sucrose cushion was recovered and immediately fixed in a final
concentration of 2% paraformaldehyde and stored at 4°C.
Formvar-coated carbon-stabilized grids were layered onto 10-ml
drops of paraformaldehyde-fixed intracellular membranes for 10
min. Grids were incubated sequentially on 0.02 M glycine/PBS (four
times) and 0.1% BSA/PBS. Grids were then incubated for 30 min
with 5-ml drops of primary antibody diluted 1:50 in 1% BSA/PBS.
After the first primary antibody incubation, the grids were washed
in 0.1% BSA/PBS (four times) and then incubated for 20 min with
5-ml drops of colloidal gold conjugated to protein A (Electron Mi-
croscopy Sciences, Fort Washington, PA) diluted in 0.1% BSA/PBS.
The grids were then washed in PBS (four times) and fixed with 1%
glutaraldehyde for 5 min. When double labeling was performed, the
grids were washed sequentially in 20 mM glycine/PBS (four times)
and then returned to the 0.1% BSA/PBS step; the second primary
antibody was then incubated, followed by incubation with a second
protein A–gold conjugate and glutaraldehyde fixation. The grids
were then washed in ultrapure H2O (seven times) and stained with
uranyl acetate:methyl cellulose (1:9; 4% uranyl acetate in 0.15 M
oxalic acid, pH 7–8, 2% methyl cellulose) for 10 min on ice. Grids
were dried and visualized with the use of a transmission electron
microscope. The order of primary antibody incubations in double-
label experiments was alternated to determine if a particular antigen
was compromised by glutaraldehyde treatment. We did not observe
any affect of glutaraldehyde fixation on the antigens used, because
the same level of labeling (number of gold particles per structure)
was observed for all antibodies both before and after glutaralde-
hyde treatment. The specificity of double labeling was checked by
omitting the second primary antibody and confirming the absence
of the second gold conjugate. Random fields were quantitated in
terms of the number of gold particles and the morphology of the
labeled structure. Specifically for the analysis in Table 1, we quan-
titated the average number of Syn7-specific gold particles per dis-
tinct membrane structure. This was also performed for structures
labeled for Rab7, CI-MPR, EEA1, and Vamp 8. To calculate the
percentage of colocalization, we then quantitated the percentage of
structures that were positive for Syn7 labeling that were also posi-
tive for one of the other markers and vice versa.
Immunoelectron microscopy of the late endosome, hybrid, and
lysosome fractions was performed as described previously (Mullock
et al., 1998) with the use of the rabbit anti-Syn7 or anti-Vamp 8
antibody at a dilution of 1:50 followed by protein A conjugated to
15-nm colloidal gold (Department of Cell Biology, University of
Utrecht, Utrecht, The Netherlands). The asialofetuin (ASF)–avidin
content of late endosomes and hybrids was sequentially immuno-
labeled with 8-nm colloidal gold as described previously (Mullock
et al., 1998). Quantitation of anti-Syn7 labeling and anti-Vamp 8
Table 1. Quantitation of immunoelectron microscopy results on subcellular fractions prepared from MDCK cells
Comparison
Structures
counted
Number of gold
particles/structure
Percent of structures labeled for
Syn7 that were labeled for
the indicated marker
Percent of structures labeled for
the indicated marker that
were labeled for Syn7
Syntaxin 7 237 7.1 32 28
EEA1 2.2
Syntaxin 7 169 8.1 51 49
VAMP 3 2.3
Syntaxin 7 263 4.1 87 84
CI-MPR 3.9
Syntaxin 7 266 3.5 84 82
VAMP 8 3.6
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labeling per micrometer on the boundary membranes of organelles
was performed with the use of intersections with a lattice overlay
method (Griffiths, 1993). Late endosomes and hybrids were defined
by their content of ASF–avidin, and random micrographs of the
lysosome preparations were scored by their electron-dense mor-
phology.
Electron Microscopy on Ultrathin Cryosections
MDCK cells were fixed in 8% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.35, for 1 h at 25°C. They were then washed with 0.2 M
phosphate buffer, scraped from the culture dish, and pelleted at
10,000 rpm in a microfuge. Cells were resuspended in warm gelatin
(10% in phosphate buffer) and repelleted at maximum speed in the
microfuge. After cooling, the gelatin-embedded cells were infil-
trated with polyvinylpyrrolidone–sucrose overnight at 4°C and
then processed for frozen sectioning as described previously (Parton
et al., 1997). Ultrathin frozen sections (60–80 nm) were labeled,
stained, and viewed (JEOL 1010, Center for Microscopy and Micro-
analysis, University of Queensland) according to published techniques
(Parton et al., 1997) with the use of gold-conjugated protein A.
Late Endosome–Lysosome Fusion Assays
Rat liver late endosomes loaded in vivo with avidin–ASF conjugate
and rat liver lysosomes loaded in vivo with 125I-labeled biotinylated
polymeric immunoglobulin A (125I-bpIgA) were resuspended sep-
arately in pig brain cytosol as described by Mullock et al. (1998).
Antibody in a total volume of 200 ml was added to each membrane
suspension to give a final volume of 700 ml. After 15 min on ice,
100-ml samples of the antibody-treated endosomes and lysosomes
were used in the standard late endosome–lysosome fusion assay in
a final volume of 240 ml for 10 min at 37°C (Mullock et al., 1998).
Immunoprecipitations
MDCK cells were washed three times in HES buffer, scraped in HES
buffer (5 ml) containing protease inhibitors (10 mg/ml leupeptin, 10
mg/ml aprotinin, 250 mM PMSF), and homogenized by 10 passes
through a 22-gauge needle. A postnuclear supernatant was obtained
by centrifuging the homogenate at 5000 3 g for 5 min. One volume
of PBS containing 2% Triton X-100 was added to the postnuclear
supernatant, which was then centrifuged at 100,000 3 g at 4°C
(TLA-45 rotor, Beckman Instruments) for 40 min. The supernatant
(protein concentration, 100 mg/ml) was then divided, and anti-Syn7
or anti-GST antibodies were added and incubated on ice for 6 h.
Fifty microliters of a 50% slurry of IgG Sorb was then added
followed by incubation for 45 min on ice. The immunoprecipitate
was separated by centrifugation and washed three times with PBS
containing 0.1% Triton X-100.
RESULTS
Syn7 Is Similar to Vam3p and Is Widely Expressed
After conducting a BLAST search of the Merck/Washington
University expressed sequence tag database, several candi-
date mammalian homologues of the yeast vacuolar syntaxin
Vam3p were identified. One expressed sequence tag that
described a candidate cDNA (GenBank accession number
H33185) was PCR amplified and used to screen a mouse
cDNA library from which we recovered a clone encoding a
266-amino acid protein with a high level of identity to the
human and rat sequences for Syn7, also known as TSL-5
(Bock and Scheller, 1997; Weimbs et al., 1997; Wong et al.,
1998b). Of the non-mammalian syntaxins, Syn7 shows the
highest level of identity (30%) with the Vam3p and Pep12p
homologues from A. thaliana, AtVam3 and AtPep12, respec-
tively (da Silva Conceicao et al. 1997; Sato et al. 1997; Sand-
erfoot et al. 1998). Overall, Syn7 shows the most homology
(50%) with mammalian Syn13, a syntaxin confined mainly to
the early endosome, indicating that these isoforms may have
related functions in the endocytic pathway (Prekeris et al.,
1998; McBride et al., 1999). Consistent with this is the obser-
vation that in A. thaliana AtVam3 shares 65% identity with
AtPep12p. Furthermore in yeast, both Pep12p and Vam3p
also occupy the endocytic system, and despite the fact that
they indeed have distinct functional roles, high-level expres-
sion of one of these syntaxins can partially substitute for the
function of the other (Darsow et al., 1997; Gotte and Gallwitz,
1997). Thus, by sequence comparisons alone, it would ap-
pear that Syn7 and Syn13 represent a pair of similar syntax-
ins that would have a role in the endocytic system as At-
Vam3 and AtPep12 have in A. thaliana and as Vam3 and
Pep12p have in S. cerevisiae. Given that Pep12p and Syn13
have been shown to function in fusion events to the endo-
some, we decided to test whether Syn7, like Vam3p, partic-
ipates in fusion events in the late endosomal/lysosomal
system (Becherer et al. 1996; McBride et al., 1999).
As a first step in this analysis, we produced both rabbit
and goat affinity-purified polyclonal antibodies with the use
of a GST fusion protein comprising the entire cytosolic tail of
Syn7. The polyclonal anti-Syn7 antibodies recognized a sin-
gle ;38-kDa protein that was expressed in all tissues exam-
ined (Figure 1). Syn7 levels were highest in brain and kid-
ney. These levels correlated with the level of Syn7 mRNA
within these tissues. The level of similarity between Syn7
and Syn13 presented the possibility that the anti-Syn7 anti-
bodies could cross-react with Syn13. To ensure the specific-
ity of the antibodies, we found that preincubation of either
of the rabbit polyclonal anti-Syn7 antibodies or the goat
anti-Syn7 antibody with a GST–Syn7 fusion protein but not
a GST–Syn13 fusion protein abolished immunoblot reactiv-
ity. Similar results were obtained in immunolocalization
experiments (see below). A mAb to Syn7 (Syn7.1C3) was
also generated and recognized a single ;38-kDa protein in
MDCK cells. Characterization of Syn7.1C3 by ELISA re-
vealed reactivity with the GST–Syn7 fusion protein but not
with the GST–Syn13 fusion protein.
Syn7 Is Localized to Late Endosomal/Lysosomal
Structures by Immunofluorescence
To facilitate our localization studies of Syn7, we surveyed
various cell types in culture for high levels of endogenous
Syn7 expression. As shown in Figure 1A, high levels were
found in MDCK cells. Thus, we initiated our immunofluo-
rescence localization studies in MDCK cells with the use of
both the rabbit and goat affinity-purified anti-Syn7 poly-
clonal antibodies (Figure 1, E–M). To ensure the specificity
of the immunolabeling procedure, we labeled MDCK cells in
the presence of either a GST–Syn7 fusion protein or a GST–
Syn13 fusion protein. No change in the labeling pattern or
the intensity of labeling was observed when the GST–Syn13
fusion protein was included during the primary antibody
incubation; however, labeling was completely abolished
with the inclusion of the GST–Syn7 fusion protein (Figure 1,
E–J). In a series of double-labeling experiments (Figure 1,
K–M), Syn7 labeling in MDCK cells was seen in intracellular
structures that were most prominent in the perinuclear re-
gion but were also found throughout the cells. There was
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Figure 1. Expression of Syn7. (A) Total membrane fractions prepared from rat brain (B), liver (L), kidney (K), spleen (S), testis (T), and
MDCK (M) cells. Aliquots (10 mg of protein) were subjected to SDS-PAGE and immunoblotting with affinity-purified rabbit anti-Syn7
polyclonal antibody (rabbit anti-Syn7#1). Total membrane fraction from MDCK cells (10 mg of protein) was immunoblotted with an
affinity-purified goat anti-Syn7 polyclonal antibody (B) or a separate rabbit antibody to Syn7 (rabbit anti-Syn7#2) (C). (D) Total membrane
fraction (10 mg protein/lane) from a clone of NRK cells (NRK-K2) stably transfected with HA epitope–tagged Syn7 was subjected to
immunoblot analysis with monoclonal anti-HA antibodies or rabbit anti-Syn7#1. (E–J) Rabbit anti-Syn7#1 (E–G) or goat anti-Syn7 antibodies
(H–J) were incubated with no additions (E and H), 300 mg/ml GST–Syn13 (F and I), or 300 mg/ml GST–Syn7 (G and J) before labeling MDCK
cells. Images were collected from a single focal plane and normalized to control. (K–M) Subconfluent MDCK cells were labeled for Syn7 with
Alexa 488–conjugated secondary antibodies (top) in combination with antibodies specific for TfR (K), EEA1 (L), or CI-MPR (M) with Texas
Red–conjugated secondary antibodies (bottom). Syn7 was labeled with the rabbit anti-Syn7#1 (K or L) or with the goat anti-Syn7 antibody
(M). Cells were imaged by collecting a 4-mm-thick z-series (step, 0.1 mm) and subjecting the series to computed deconvolution before
assembling a maximum point projection representing a 1-mm-thick plane. Arrows point to structures that are positive for two markers, and
arrowheads point to structures that are positive for only one marker. N, nucleus. Bars, 15 mm for E–J; 5 mm for K–M.
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little overlap between Syn7 and syntaxin 6, a trans-Golgi
network marker (Bock et al., 1997). The labeling pattern for
Syn7 was quite distinct from that of the early endosome
marker EEA1, which is generally concentrated in sorting
endosomes in MDCK cells (Mu et al., 1995; Stenmark et al.,
1996). Some overlap with Syn7 labeling was observed in
double-labeling experiments with transferrin receptor (TfR),
a more general marker of the recycling endocytic system.
However, the extent of colocalization with TfR was poor
because a considerable amount of labeling was observed in
TfR-negative structures. In contrast, we found the highest
level of colocalization was with the CI-MPR, which is con-
centrated in late endosomes in MDCK cells (Griffiths et al.,
1988).
Because of the overlap of Syn7 with the CI-MPR in MDCK
cells, we examined the distribution of Syn7 in relation to
lgp120, a well-established marker of late endosomes and
lysosomes (Lewis et al., 1985). Antibodies to lgp120 available
to us did not cross-react with MDCK cells, and because we
subsequently wanted to use a cell-free late endosome–lyso-
some fusion system from rat liver, we chose to examine Syn7
in WIF-B cells. WIF-B is a hepatic cell line that possesses
many of the characteristic features of polarized hepatocytes,
including the formation of the apical bile canalicular mem-
brane (Ihrke et al., 1993; Shanks et al., 1994). We also took
further steps to ensure the specificity of our labeling proce-
dure with the use of a mAb raised against the cytosolic
domain of Syn7 (Syn7.1C3). This mAb also recognizes a
single 38-kDa protein in MDCK cell membrane fractions,
and the binding of the antibody was specifically competed
with GST–Syn7 fusion protein but not with GST–Syn13 fu-
sion protein. Figure 2 shows that Syn7 was concentrated
within the perinuclear region of WIF-B cells, well away from
the periphery of the cell, where early endosomes are typi-
cally located. Double labeling for lgp120 showed a high level
of colocalization in vacuolar structures. In contrast, Syn13
showed very little colocalization with lgp120 but extensive
overlap with TfR, consistent with previous analyses indicat-
ing that Syn13 populates early endosomes and catalyzes
early endosome homotypic fusion (Prekeris et al., 1998;
McBride et al., 1999).
Although in the studies described above of MDCK and
WIF-B cells we used polyclonal and monoclonal antibodies
that do not cross-react with Syn13 or other syntaxins with
molecular weights different from that of Syn7 (Figure 1), we
could not completely eliminate the possibility that our anti-
bodies cross-reacted with another protein in our immuno-
fluorescence studies. Therefore, we chose to localize an
epitope-tagged version of Syn7 in which we inserted two
HA epitopes immediately after the initiation codon. The site
for tag insertion has been used with a variety of other
syntaxins and in those cases did not result in missorting of
the syntaxin (Banfield et al., 1994; Advani et al., 1998; Carr et
al., 1999). To analyze the distribution of epitope-tagged
Syn7, we chose a cell line (NRK) in which the various
compartments of the endocytic system can be distinguished
morphologically and in which the localization and biogen-
esis of lysosomes have been characterized extensively
(Bright et al., 1997). A stable clonal NRK cell line (NRK-K2)
was isolated after transfection with a plasmid (pRCP316)
encoding HA-tagged Syn7 and subsequent screening for
G418-resistant cells. Western blot analysis of whole cell ex-
tract from NRK-K2 cells showed that the HA-tagged Syn7
was expressed as a single species with an apparent molec-
ular mass ; 3 kDa larger than endogenous Syn7 (Figure 1D).
Immunoblotting the same extract with anti-Syn7 antibody
showed that the level of the epitope-tagged Syn7 was far less
than that of the endogenous Syn7 (Figure 1D). As shown in
Figure 3, the HA-Syn7 was distributed in large intracellular
structures around the nucleus that showed significant over-
lap with lgp120. In contrast, very little overlap was observed
between HA-Syn7 and TfR (which was found within a large
tubular network). Furthermore, labeling of HA-Syn7 was
distinct from that of EEA1 and Syn13, both of which were
found in punctate structures throughout the cytoplasm. The
observation that epitope-tagged Syn7 colocalized with
lgp120 agrees well with the localization of endogenous Syn7
in MDCK and WIF-B cells.
Syn7 Is Localized to Late Endosomes and
Lysosomes by Immunoelectron Microscopy
The colocalization of Syn7 with lgp120 by immunofluores-
cence in WIF-B and NRK cells indicated that a significant
proportion of Syn7 is localized to late endosomes and lyso-
somes. Yet the lower levels of Syn7 coinciding with TfR-
containing compartments by immunofluorescence (Figure
1K) in MDCK cells indicated that some Syn7 may also oc-
cupy earlier endosomal compartments. To characterize fur-
ther the intracellular localization of Syn7 in MDCK cells, we
examined ultrathin cryosections and isolated membranes by
immunogold electron microscopy. Specific labeling for Syn7
was observed in the perinuclear region of the cell associated
with multivesicular endosomes (Figure 4A). In addition,
labeling was often observed on small tubulovesicular struc-
tures in close association with these multivesicular endo-
somes. However, despite the use of only the mild fixative
paraformaldehyde, labeling on cryosections was invariably
low. This proved problematic for convincing double-label-
ing experiments, so we adopted a procedure previously
used to analyze GLUT-4–containing vesicles (Martin et al.,
1996). A postnuclear supernatant was prepared from MDCK
cells, fixed in paraformaldehyde, adsorbed to Formvar-
coated grids, and labeled with antibodies to Syn7, CI-MPR,
Rab7, and Vamp 3 (cellubrevin). Specific labeling for Syn7
was observed on large, electron-dense, multivesicular struc-
tures (Figure 4, B–D) that were similar to those structures
labeled on cryosections. A large proportion of the structures
that were positive for Syn7 labeling also showed labeling for
the late endosome marker CI-MPR (Griffiths et al., 1988). In
contrast, only a minor proportion of the structures that were
positive for Syn7 showed labeling for EEA1 (Table 1), and
most of the EEA1 labeling was restricted to small electron-
lucent structures, confirming that the bulk of Syn7 and EEA1
occupy different compartments.
We also examined the distribution of Syn7 in late endo-
somes and lysosomes isolated from rat liver (Figure 5, A and
C) not only to confirm the localization of Syn7 that we
observed in lgp120-positive structures in the hepatocyte
WIF-B cell line but also because we used a cell-free late
endosome–lysosome fusion reaction with the use of mem-
branes derived from liver cells (see below). In addition, we
examined the distribution of Syn7 in hybrid organelles
formed after the in vitro late endosome–lysosome fusion
assay (Figure 5B). Based on our previous pulse-chase studies
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with endocytosed ASF–avidin in whole livers, we prepared
liver membrane fractions from rats that had been injected
with ASF–avidin 6 min before killing, because this proce-
dure results in the enrichment of ASF–avidin in multivesicu-
lar late endosomes (Mullock et al., 1994, 1998). Quantitation
of ASF–avidin in these structures showed that there were 33
gold particles/mm2 compared with 0.5 gold particles/mm2
over other tissue components of the pellet, thus defining late
endosomal structures. Lysosomes and late endosome–lyso-
some hybrids were identified in enriched fractions by their
characteristic morphology. As shown in Figure 5, late endo-
somes, hybrids, and lysosomes showed significant labeling
for Syn7, with the highest labeling seen on lysosomes (Fig-
ure 5D). Together, these data show that Syn7 is enriched in
late endosomes and lysosomes. However, these data do not
exclude the possibility that lower levels of Syn7 are distrib-
uted in earlier endocytic compartments. Therefore, we em-
barked on functional studies aimed at substantiating the
proposed role of Syn7 in mediating fusion events to the late
endosome.
Figure 2. Distribution of Syn7 and Syn13
in WIF-B cells by confocal microscopy. Po-
larized WIF-B cells were fixed and perme-
abilized and then double-labeled with an-
tibodies to Syn7 and lgp120 (A), Syn13 and
lgp120 (B), or Syn13 and TfR (C). Mouse
mAbs were used to label Syn7 (A), lgp120
(B), and TfR (C) with rabbit polyclonal an-
tibodies labeling lgp120 (A) and Syn13 (B
and C). FITC-conjugated antibodies to
mouse IgG (A, Syn7; B, lgp120; C, TfR) and
Cy3-conjugated antibodies to rabbit IgG
(A, lgp120; B and C, Syn13) were used as
secondary antibodies. Optical sections in A
and B are through the middle of the cells,
whereas the section in C is slightly closer to
the substratum to show more peripheral
endosomes. Arrows point to structures that
are positive for two markers, and arrow-
heads point to structures that are positive
for only one marker. Note the good coinci-
dence of Syn7 with lgp120-positive struc-
tures, i.e., lysosomes (A), and of Syn13 with
TfR, i.e., early endosomes (C), whereas lit-
tle overlap is seen between Syn13 and
lgp120 (B). BC, bile canalicular-like space;
N, nucleus. Bar, 10 mm.
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Figure 3. Localization of epitope-
tagged Syn7 in NRK cells by confo-
cal microscopy. Stably transfected
NRK cells expressing an HA epito-
pe–tagged Syn7 (NRK-K2 cells)
were labeled for HA with the use of
monoclonal anti-HA antibodies (A,
C, and D, left) or rabbit anti-HA
polyclonal antibodies (B, left) in
combination with rabbit polyclonal
antibodies to Syn13 (A, middle),
mouse mAbs to TfR (B, middle),
rabbit polyclonal antibodies to
lgp120 (C, middle), or rabbit poly-
clonal antibodies to EEA1 (D, mid-
dle). E shows labeling with anti-
lgp120 rabbit polyclonal antibodies
(left) with anti-EEA1 mAbs (mid-
dle). Images were collected from a
0.5-mm focal plane by confocal mi-
croscopy. Note that variations in
the distribution of Syn7 result from
the different focal planes selected to
show the localization of epitope-
tagged Syn7 relative to each marker
protein. Green/red merged images
are shown on right. Bar, 10 mm.
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Antibodies to Syn7 Inhibit the Fusion of Late
Endosomes with Lysosomes
Given the distribution of Syn7, we sought to determine
whether Syn7 played a role as a t-SNARE that can coordi-
nate specific fusion events between late endosomes and
lysosomes. Previous studies have established an in vitro
system that reconstitutes one of the last steps in lysosomal
biogenesis, i.e., the fusion of late endosomes with lysosomes.
This assay measures content mixing between distinct com-
partments containing either ASF–avidin or 125I-bpIgA by
immunoprecipitating the avidin and quantitating the level
of bound 125I-bpIgA. Labeled late endosomes are obtained
from rat livers allowed to uptake ASF–avidin for 6 min,
whereas labeled lysosomes are obtained by allowing uptake
of 125I-bpIgA for 30 min. Fusion between these two com-
partments has been shown to require ATP and cytosol and is
dependent on NSF and Rab proteins (Mullock et al., 1994,
1998).
Both the late endosome and lysosome fractions were la-
beled with anti-Syn7 antibodies (Figure 5, A–C), and there-
fore both were treated with anti-Syn7 antibodies before the
fusion reaction. We found that a 15-min preincubation at 4°C
of the late endosomes and lysosomes with affinity-purified
anti-Syn7 antibody significantly inhibited content mixing
between these compartments after the reaction was initiated
by combining fractions and incubating at 37°C. With the use
of affinity-purified antibodies from two separate rabbit anti-
Syn7 antisera (#1 and #2), the inhibition was dose-dependent
and specific to anti-Syn7 antibodies (Figure 6A). Antibodies
to the CI-MPR cytosolic tail had no effect at the same con-
centrations. In our initial experiments, we used the anti-Syn7
that was purified from the first rabbit we immunized (anti-
Syn7#1). At the highest concentration used (80 mg/ml), we
observed a 45% inhibition of fusion. However, increasing
the antibody concentration in hopes of achieving complete
inhibition was technically difficult. Therefore, we tested an-
tibodies raised in additional animals. One such antibody
was the goat anti-Syn7, which resulted in consistent and
specific inhibition but which had a lower specific inhibitory
activity than the affinity-purified rabbit anti-Syn7#1. An-
Figure 4. Immunogold electron microscopic localization of Syn7 in MDCK cells. (A) Ultrathin cryosections were labeled with a specific
affinity-purified antibody against Syn7 (anti-Syn7#1) followed by 15-nm protein A–gold. Specific labeling (arrowheads) was observed in the
perinuclear region of the cell associated with multivesicular endosomes (e). (B–D) Intracellular MDCK membranes were fixed with
paraformaldehyde and adsorbed to Formvar-coated grids. Membranes were then sequentially double labeled for Syn7 (15-nm protein
A–gold; S7) and CI-MPR (20-nm protein A–gold; MPR) (B); Syn7 (20-nm protein A–gold; S7) and Rab7 (10-nm protein A–gold; R7) (C); or
Syn7 (10-nm protein A–gold; S7) and EEA1 (15-nm protein A–gold) (D). Bar, 300 nm
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other rabbit antibody against Syn7 (anti-Syn7#2) proved to
have an approximately fourfold higher level of specific in-
hibitory activity, yielding 48% inhibition at only 20 mg/ml
and complete inhibition at and above 40 mg/ml. All three
affinity-purified polyclonal antibody preparations were spe-
cific for Syn7 by immunoblotting. Neither an anti-syntaxin 6
antibody nor an anti-GST antibody purified in an identical
manner nor anti-Syn7 antibodies that had been preincubated
with the GST–Syn7 fusion protein affected the content-mix-
ing assay (Figure 6B). Steric hindrance was not responsible
for the inhibition by anti-Syn7 antibodies because monova-
lent Fab fragments prepared from the most inhibitory rabbit
polyclonal antibody (anti-Syn7#2) also inhibited fusion by
.70% at 45 mg/ml (Figure 6B).
Syn7 Complexes with the Endocytic v-(R)-SNARE
Vamp 8
Because it is a syntaxin (Q-SNARE), we would predict that
Syn7 would specifically complex with a subset of v-SNARE
Figure 5. Immunogold electron microscopy of Syn7
and Vamp 8 associated with rat liver late endosomes,
lysosomes, and hybrid organelles. Immunoelectron
microscopy of Syn7 (A–C) labeling with the use of
rabbit anti-Syn7#1 (15-nm gold; large arrowheads),
Vamp 8 (E–G) labeling (15-nm gold; large arrow-
heads), and internalized ASF-avidin (A, B, E, and G)
(8-nm gold; small arrowheads) associated with rat
liver late endosomes (A and E), hybrid organelles (B
and F), and lysosomal fractions (C and G). Late en-
dosomes and hybrid organelles were identified by
their content of ASF–avidin. Lysosomes were identi-
fied by their electron-dense morphology. Bar, 200
nm. (D and H) Quantitation of the level of Syn7
labeling (D) and Vamp 8 labeling (H) on the periph-
eral membrane of late endosomes (le; 30 mm scored),
hybrid organelles isolated after late endosome–lyso-
some fusion in the cell-free fusion system (h; 65 mm
scored), and lysosomes isolated after incubation with
cytosol and ATP under the conditions of the cell-free
fusion system (ly; 1000 mm scored). Error bars repre-
sent SEM for the number of organelles scored.
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proteins (R-SNARE) to mediate fusion events with the late
endosome and lysosome. Thus, in an effort to identify a
putative v-SNARE partner for Syn7, we once again exploited
the analogy between the yeast syntaxin, Vam3p, and its
putative mammalian counterpart, Syn7. The work of Wick-
ner and colleagues (Nichols et al., 1997; Ungerman et al.,
1998, 1999) has established a role for Vam3p and the
v-SNARE Nyv1p in fusion events within the late endocytic
system of yeast, i.e., homotypic fusion of vacuoles. Further-
more, a significant proportion of these proteins are found in
a complex, as demonstrated by coimmunoprecipitation ex-
periments. Therefore, we searched the database for
v-SNAREs that showed the highest level of identity with
yeast Nyv1p. Although only low levels of identity were seen
among the known mammalian v-SNAREs, the closest rela-
tive was Vamp 8, which has been localized to endocytic
compartments (Advani et al., 1998; Wong et al., 1998b).
Therefore, we determined whether Vamp 8 was associated
with Syn7 by coimmunoprecipitation experiments. Figure
7A shows the specificity of the affinity-purified anti-Vamp 8
antibody generated to the cytosolic domain of Vamp 8. As
reported previously, Vamp 8 migrates as an ;17-kDa pro-
tein that is enriched in endosomal compartments (Wong et
al., 1998a). Syn7 was immunoprecipitated from a Triton
X-100–soluble fraction prepared from MDCK cells and then
immunoblotted for Vamp 8 and Vamp 3 (cellubrevin) (Fig-
ure 7B). Immunoprecipitations performed with either the
goat anti-Syn7 or the rabbit anti-Syn7#1 antibody resulted in
a quantitative recovery of Syn7 in the immunoprecipitate.
Blotting for candidate Vamps showed that 10–20% of the
total Vamp 8 was associated with Syn7, whereas no detect-
able Vamp 3 was found associated with the immunoprecipi-
tated Syn7.
Consistent with our finding of a specific complex between
Vamp 8 and Syn7, we also observed a significant level of
overlap in the localization of Vamp 8 and Syn7 by immu-
nofluorescence in MDCK cells (Figure 7C). This colocaliza-
tion was confirmed by immunoelectron microscopy labeling
of MDCK membranes (Table 1). Despite this colocalization,
there were other Vamp 8–positive structures that were dis-
tinct from those positive for Syn7. One possibility is that
Vamp 8 is restricted only to early endosomal compartments
and that the overlap between Syn7 and Vamp 8 reflects the
low level of Syn7 in early endosomal compartments. To
determine whether any Vamp 8 occupied late endosomes or
lysosomes, we also localized Vamp 8 by double-label immu-
nofluorescence in WIF-B cells (Figure 7D) and by immuno-
electron microscopy on isolated late endosome and lyso-
some fractions from rat liver (Figure 5, E–G). These
experiments showed significant localization of Vamp 8 to
lgp120-positive structures. Interestingly, by immunoelectron
microscopy, Vamp 8 was enriched in late endosomes but far
less so in lysosomes (Figure 5H). Thus, although Vamp 8
and Syn7 are localized to late endosome/lysosome compart-
ments, the general distribution of each protein is different
throughout the endocytic system.
DISCUSSION
Our effort to characterize the function of Syn7 was moti-
vated by hopes of finding a functional homologue of the
yeast Vam3p that would play a role in the late stages of
Figure 6. Syn7 antibodies specifically inhibit late endosome–lyso-
some fusion in vitro. (A) Titration experiment assaying content mixing
between rat liver late endosomes and lysosomes. Effects of affinity-
purified rabbit antibodies to Syn7#1 (closed squares) and Syn7#2
(closed circles) and rabbit antibodies to the cytosolic tail of the CI-MPR
(open circles) were measured after treating the two fractions separately
with the indicated concentrations of antibodies for 15 min on ice and
keeping the antibodies present during the cell-free late endosome–
lysosome fusion assay. Standard fusion (100%) is defined as the
amount of fusion obtained after preincubation with buffer only, i.e.,
without the addition of antibodies. Data are presented as means 6
SEM of duplicate samples from six separate experiments for anti-CI-
MPR, five separate experiments for anti-Syn7#1 at 20 mg/ml, four
separate experiments for anti-Syn7#1 at 40 mg/ml, three separate ex-
periments for anti-Syn7#2 at 20 mg/ml, and two separate experiments
for anti-Syn7#1 at 80 mg/ml. All other data presented are means of
duplicate samples. (B) Summation of several experiments with the
indicated antibodies to perturb the fusion assay between late endo-
somes and lysosomes. Before fusion, both late endosomes and lyso-
somes were preincubated with buffer only (Control) or the following
antibodies at 40 mg/ml: anti-CI-MPR, affinity-purified antibodies to the
cytosolic tail of the CI-MPR; anti-Syn7#1, affinity-purified antibodies to
the cytosolic domain of Syn7 from serum #1; absbd anti-Syn7#1, pre-
incubation with anti-Syn7#1 previously absorbed with GST–Syn7
(equivalent to anti-Syn7#1 in the assay at 40 mg/ml); anti-Syn7#2,
affinity-purified antibodies to the cytosolic domain of Syn7 from serum
#2; anti-syntaxin 6, affinity-purified antibodies to the cytosolic domain
of syntaxin 6; and anti-GST, affinity-purified antibodies (40 mg/ml) to
GST. Anti-Syn7(Fab), Fab fragments prepared from anti-Syn7#2 anti-
body were used at 45 mg/ml. Data presented are means of duplicate
samples or means 6 SEM in cases of three or more separate experi-
ments.
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lysosomal biogenesis. We present two major findings that
support a role for Syn7 in lysosomal biogenesis. First, Syn7
is localized to late endosomes and lysosomes. Second, Syn7
is required for the fusion of late endosomes with lysosomes
in vitro.
The mouse sequence we identify here is 93 and 94%
identical to human and rat Syn7, respectively. Outside of the
animal kingdom, mammalian Syn7 shows the highest level
of identity (;30%) with the plant Vam3p homologue
AtVam3p, which like its proposed yeast counterpart is lo-
calized to the vacuole (Sato et al., 1997). Furthermore, Syn7 is
expressed in all tissues examined, consistent with the role
we hypothesize it fulfills in the endosomal system. By im-
munofluorescence microscopy, immunoelectron micros-
copy, and subcellular fractionation analysis, we find that
significant levels of Syn7 occur in late endosomes and lyso-
somes and much less in EEA1-positive compartments.
As a potential partner v-SNARE for Syn7, we found that
Vamp 8 partially colocalized with Syn7 and that a significant
proportion of Vamp 8 is associated with Syn7 in immuno-
precipitates from detergent-solubilized fractions prepared
from MDCK cells. Whether Syn7 and Vamp 8 represent a
SNARE pair that operates in vivo needs to be interpreted in
light of recent experiments conducted in vitro that indicate
that v-(R)-SNAREs can form complexes with many different
t-(Q)-SNAREs in a manner that belies the specificity of the
trafficking event they may catalyze in vivo (Yang et al., 1999).
In contrast to these in vitro studies, we found a significant
amount of Syn7 in a complex with Vamp 8 by immunopre-
cipitation from cell extracts, indicating that this complex
exists in vivo. Syn7 was not observed in a complex with the
v-SNARE Vamp 3 (cellubrevin), which in MDCK cells shows
less colocalization with Syn7 than Vamp 8 (Table 1) and
which has previously been localized to endosomes (McMa-
hon et al., 1993; Chilcote et al., 1995; Daro et al., 1996). Thus,
the specificity of the Syn7/Vamp 8 complex we observed
diminishes the likelihood that the association of Syn7 and
Vamp 8 is serendipitous as a result of their transit through
the same compartment, because some Vamp 3 would be
predicted to coprecipitate given the extent of colocalization
Figure 7. Immunofluorescence localiza-
tion and coimmunoprecipitation of Vamp 8
with Syn7. (A) Specificity of Vamp 8 anti-
bodies was demonstrated by subjecting
whole cell extracts of MDCK cells to SDS-
PAGE and immunoblotting with affinity-
purified rabbit anti-Vamp 8 antibodies. (B)
A Triton X-100–soluble fraction was pre-
pared from a postnuclear supernatant from
MDCK cells and allowed to incubate with
the affinity-purified rabbit anti-Syn7 anti-
body or the rabbit anti-GST antibody (left
panels) or the affinity-purified goat anti-
Syn7 antibody and a matching goat anti-
GST antibody (right panels). Fixed S. aureus
cells were then added, and immunoprecipi-
tates were washed, subjected to nonreduced
SDS-PAGE, and immunoblotted for Syn7,
Vamp 8, and Vamp 3. One-fifth of the cor-
responding supernatant from the immuno-
precipitate was also immunoblotted. For
immunoprecipitations with the rabbit anti-
Syn7#1 antibody, the goat anti-Syn7 anti-
body was used for immunoblot analysis.
For immunoprecipitations with the goat an-
ti-Syn7 antibody, the rabbit anti-Syn7#1 an-
tibody was used for immunoblot analysis.
SDS-PAGE was performed under nonre-
ducing conditions. (C) MDCK cells were la-
beled with goat anti-Syn7 (left) and rabbit
anti-Vamp 8 (right) in combination with
FITC-conjugated donkey anti-goat and
Texas Red–conjugated donkey anti-rabbit
secondary antibodies. Matched 1-mm-thick
planes from a deconvoluted 4-mm-thick z-
series are shown (D). Polarized WIF-B cells
were fixed and permeabilized, double la-
beled with rabbit anti-Vamp 8 (left) and
mouse anti-lgp120 (right), and imaged by
confocal microscopy. Primary antibodies
were followed by Cy3- and FITC-conju-
gated secondary antibodies, respectively. In
C and D, arrows point to structures that are
positive for both markers, and arrowheads indicate structures that contain only one marker. BC, bile canalicular-like space; N, nucleus. Bar,
10 m m.
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we observed. Because of the specific association of Vamp 8
and Syn7 and the degree of colocalization we observed by
immunofluorescence and by immunoelectron microscopy
studies, we propose that Vamp 8 may be at least one of the
v-SNARE partners that functionally interacts with Syn7 in
vivo. This does not preclude Vamp 8 or Syn7 from interact-
ing with other SNAREs to effect a variety of fusion events
within the endocytic system. Further experiments are re-
quired to determine which transport steps this putative
SNARE pair controls, because to date we have failed to show
inhibition of fusion between late endosomes and lysosomes
in the cell-free assay with the use of the single anti-Vamp 8
rabbit antiserum we have prepared.
Given the localization of Syn7 as well as the effect of
anti-Syn7 antibodies and Fab fragments on the fusion of late
endosomes and lysosomes in vitro, we believe that Syn7
participates in fusion events within the late endocytic path-
way. This is in contrast to the function of the close homo-
logue Syn13, which shares 50% identity with Syn7 and is
also localized to the endocytic pathway. Syn13, however, is
concentrated in early endosomes and participates with rab5
and EEA1 in the fusion of early endosomes (Prekeris et al.,
1998; McBride et al., 1999). So far, no role for Syn7 has been
found in early endosome fusion (McBride et al., 1999). Thus,
Syn7 and Syn13, like their putative counterparts Vam3p and
Pep12p, are likely to have distinct, nonoverlapping func-
tions. Using an in vitro fusion reaction that measures content
mixing between endosomes and lysosomes isolated from rat
liver (Mullock et al., 1994, 1998), we were able to substantiate
that Syn7 is likely to have a functional role in at least one
fusion event with the lysosome in vivo. No vesicular carrier
has been identified for transport from the late endosome to
the lysosome in either mammalian or yeast cells. In contrast,
it has been shown that this transport reaction is character-
ized by the fusion of large multivesicular endosomes with
preexisting lysosomes (Futter et al., 1996; Mellman, 1996;
Storrie and Desjardins, 1996; Mullock et al. 1998). In vitro,
this fusion reaction results in the production of morpholog-
ically distinct late endosome–lysosome hybrids that can also
be observed in vivo (Futter et al., 1996; Bright et al., 1997;
Mullock et al., 1998). Previous studies have shown that this
fusion reaction is dependent on NSF and a and g SNAPs and
is also sensitive to exogenous Rab GDI, a hallmark for the
requirement of Rab GTPases (Mullock et al., 1998). These
findings are consistent with the involvement of SNARE
proteins in this fusion reaction, because it is well established
that this cohort of proteins acts together to promote fusion
(Lian et al., 1994; Sogaard et al., 1994; Luapshin and Waters,
1997). Syn7 appears to be one of the SNARE proteins in this
fusion step, because antibodies directed to the cytosolic tail
of Syn7 inhibited content mixing in a dose-dependent man-
ner. The complete inhibition of content mixing observed
with anti-Syn7#2 is consistent with the total inhibition of
yeast vacuole fusion observed in a cell-free assay in the
presence of anti-Vam3p (Nichols et al., 1997)
Wong and colleagues (1998b) reported that Syn7 was lo-
calized to early endosomes based on partial colocalization
with the TfR. Although we find low levels of Syn7 in TfR-
positive structures in MDCK cells, most of the labeling we
observe is found coincident with markers of late endosomes
and/or lysosomes. In the studies of Wong and colleagues,
the TfR was labeled after the internalization of antibodies
directed to the lumenal domain of the TfR, which, if in
excess, may have also entered late endosomes and lyso-
somes and could have obscured detection of Syn7 in early
compartments. Recent studies by Prekeris et al. (1999) that
used immunogold labeling of cryosections indicated that
Syn7 was restricted to clathrin-coated vesicles budding from
early endosomes and was far more restricted in its localiza-
tion pattern than the overlap with TfR that was reported by
Wong et al. (1998b). Although the labeling observed in these
immunoelectron microscopy studies was discrete and spe-
cific, the possibility remains that only a subset of the intra-
cellular Syn7 molecules was detected under the fixation and
labeling methods used. In our experiments, we saw a far
more broad distribution of Syn7 by a variety of techniques.
During the course of our immunoelectron microscopy ex-
periments, however, we generated rabbit antibodies, a goat
antibody, and a mouse mAb to Syn7 to use in immunogold
labeling of cryosections. Although we observed specific la-
beling that was associated with late endosomal structures,
we were unable to boost the overall level of immunogold
labeling in sections, indicating that many of the Syn7
epitopes were obscured by this method despite our attempts
with many different antibody preparations. Furthermore,
when we labeled lysosomal fractions isolated from rat liver,
we found the labeling efficiency to increase significantly
when we incubated the fraction in cytosol and ATP before
fixation and cryosectioning. Thus, the highly restricted lo-
calization of Syn7 in the studies of Prekeris and others may
be due in part to the selective detection of a subpopulation
of Syn7 that may reside in a specific protein complex (Prek-
eris et al., 1999). Our conclusion that Syn7 is distributed
throughout the endocytic pathway and concentrated in late
endosomes and lysosomes is based on a variety of immu-
nofluorescence and immunoelectron microscopy localiza-
tion studies that were performed in MDCK cells, NRK cells
expressing epitope-tagged Syn7, and hepatocytes (e.g., rat
liver and WIF-B cells) in which Syn7 was largely colocalized
with markers of late endosomes and lysosomes. By electron
microscopy, Syn7 was found on multivesicular endosomes
that also labeled with antibodies to CI-MPR and Rab7 (Fig-
ure 4) or that contained internalized avidin-conjugated ASF
(Figure 5). Importantly, we also found significant levels of
Syn7 on the limiting membrane of lysosomes isolated from
rat liver (Figure 5) at even higher levels than that observed
for late endosomes also isolated from rat liver. Consistent
with our localization results is recent work by Nakamura et
al. (2000), who also found Syn7 localized to late endosomes
and lysosomes in colabeling experiments with LAMP1 (the
mouse homologue of rat lgp120). Furthermore, these au-
thors provide evidence for a functional role for Syn7 in the
late endocytic pathway by examining the effects of overex-
pressing the cytosolic domain of Syn7 to induce a dominant-
negative effect. This resulted in a block in the transfer of
endocytosed material from early endosomes to late endo-
somes. These results must be interpreted carefully, because
the dominant-negative Syn7 works by titrating out Syn7-
binding proteins that might function elsewhere. Also, solu-
ble fragments of Syn7 may be able to bind promiscuously to
inappropriate SNARE partners. Our results in vitro support
a role for Syn7 per se in late endosome–lysosome fusion, and
it will be interesting to determine exactly how Syn7 func-
tions in vivo. In this regard, experiments aimed at assigning
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the exact function of Syn7 are reminiscent of a similar anal-
ysis of the role of Rab7. Experiments with the use of hyper-
active Rab7 and biochemical in vitro fusion experiments
have implied and/or shown a direct role for Rab7 and its
yeast homologue Ypt7p in the fusion of lysosomes and
vacuoles in animal and yeast cells, respectively (Haas et al.,
1995; Bucci et al., 2000). However, analysis of dominant-
negative Rab7 in transfected cells supports the conclusion
that Rab7/Ypt7p participates in early to late endosome
transport (Press et al., 1998). These results may mean that
Rab7, or in our case Syn7, works at multiple steps in the late
endocytic pathway or could mean that interruption of nor-
mal lysosomal fusion events results in indirect effects earlier
in the endocytic pathway. At the very least, we believe that
our results substantiate a role for Syn7 in the process of late
endosome–lysosome fusion.
Given that Syn7 is found in both late endosomes and
lysosomes, the question arises whether Syn7 catalyzes fu-
sion as a t-SNARE on the lysosomal membrane or on the late
endosome. Perhaps the best model for Syn7 function is
exemplified by the yeast Vam3p, which has been shown to
mediate homotypic fusion of yeast vacuoles (Nichols et al.,
1997). This fusion reaction is dependent on NSF, Ypt7p (a
Rab7 homologue), Vam3p, and Nyv1p (a v-SNARE). The
best model is that Vam3p and the v-SNARE Nyv1p are not
only present but are functionally active on both fusion part-
ners (Nichols et al., 1997; Ungermann et al., 1998). Thus, Syn7
may be active on both late endosomes and lysosomes and
catalyze fusion events from a number of different pathways
that converge at late endosomal/lysosomal compartments.
This would be consistent with the multifaceted role of
Vam3p, which catalyzes not only fusion of endosomes with
the vacuole but also fusion of autophagic vesicles with the
vacuole and delivery of transport intermediates derived
from the AP-3 transport pathway originating from the Golgi
(Cowles et al., 1997; Darsow et al., 1997; Piper et al., 1997).
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